BOSTON--(BUSINESS WIRE)--DiaKine Therapeutics, Inc., the developer of drugs designed to cause diabetes to go into remission, today announced that it has been selected as a winner of the annual New England Venture Summit Top Innovator award by youngStartup Ventures. The list of privately held companies recognizes those that play a leading role in innovation for the Technology, Life Sciences and Clean-tech sectors.
